arrow_back Back to App

Faster Access to Foreign-Approved Medicines and Medical Devices

This act aims to speed up access to drugs, biological products, and medical devices in the U.S. that are already approved and legally marketed in certain countries, such as the United Kingdom. This means citizens could get quicker access to new, potentially life-saving treatments already available abroad, provided they meet specific safety and medical need criteria.
Key points
Drugs and medical devices approved in the UK or other specified countries can be marketed faster in the U.S.
Approval decisions will be made within 30 days, significantly reducing waiting times.
The FDA can deny approval if a product is deemed unsafe or ineffective, ensuring patient safety.
The act aims to address unmet medical needs and improve public health in the U.S.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_154
Sponsor: Sen. Cruz, Ted [R-TX]
Process start date: 2021-02-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_154.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-02-02.

What are the main provisions?

Key points include:

  • Drugs and medical devices approved in the UK or other specified countries can be marketed faster in the U.S.
  • Approval decisions will be made within 30 days, significantly reducing waiting times.
  • The FDA can deny approval if a product is deemed unsafe or ineffective, ensuring patient safety.
  • The act aims to address unmet medical needs and improve public health in the U.S.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cruz, Ted [R-TX].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health